Drug Development

Paul Kippax is a product manager, Laser Diffraction, Malvern Instruments Ltd., Enigma Business Park, Grovewood Road, Malvern Worcestershire, UK WR14 1XZ, Paul.Kippax@malvern.co.uk.

Articles

Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.

Analytical Techniques for Oral Solid Dosage Formulation

PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.

Simplify Formulation With PAT

Agnes Shanley is senior editor of Pharmaceutical Technology.

Ionic liquid technologies offer a new way to improve bioavailability.

Boosting Solubility in Lipid-Based Formulations

New cellulosic polymers have been shown to improve solubility in these key amorphous solid dispersion processes.

Using Polymers for More Efficient Hot-Melt Extrusion and Spray Drying

BIO and the Colorado BioScience Association urge Colorado Governor Hickenlooper to sign a bill that will help patients gain access to interchangeable biologic products following FDA approvals.

BIO Encourages Transparency with Support of Biologic Interchangeability Bill

Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.

Mallinckrodt Accents Critical Care With Ikaria Acquisition

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.

WHO to Launch Ebola Vaccine Efficacy Trial March 7

In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.

FDA Approves First Biosimilar

Baxter has bought SuppreMol, a German biopharmaceutical company that focuses on autoimmune treatments, for €200 million ($225 million USD).

Baxter Builds Immunology Portfolio by Acquiring Autoimmune Specialist

Canon announced that it established Canon BioMedical, a wholly owned biomedical business to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform.

Formulation and Drug Delivery